Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

Press releases published on May 27, 2026

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
Satellos to Participate in Upcoming Investor Conferences
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026
Axsome Therapeutics to Participate in Upcoming Investor Conferences
BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
Korro to Present at the 2026 Jefferies Global Healthcare Conference
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision®
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
InnoCare Announces Approval of Orelabrutinib in Australia

Share this page:

Sign up for:

Iowa Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.